Literature DB >> 1446784

Identification of G protein alpha subunit mutations in human growth hormone (GH)- and GH/prolactin-secreting pituitary tumors by single-strand conformation polymorphism (SSCP) analysis.

R T Drews1, R A Gravel, R Collu.   

Abstract

We have applied the polymerase chain reaction (PCR) and single-strand conformation polymorphism analysis (SSCP) to detect activating mutations in the Gs alpha subunit gene, amplifying genomic DNA extracted from growth hormone (GH)- and GH/prolactin (PRL)-secreting human pituitary tumors. Of 15 tumors tested six contained mutations in the analyzed regions of the Gs alpha. SSCP analysis revealed band shift in exon 8 in four GH- and in one GH/PRL-secreting tumors, and in exon 9 in one GH/PRL-secreting tumor. Direct sequencing of PCR reaction products identified the mutations as R201-H, R201-S and R201-C in exon 8 and Q227-L in exon 9. These results show the efficacy of PCR/SSCP analysis in the detection of G protein mutations and extend the generalization that these sites are hot spots in tumor-inducing mutations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1446784     DOI: 10.1016/0303-7207(92)90240-7

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  9 in total

Review 1.  Novel insights into G protein and G protein-coupled receptor signaling in cancer.

Authors:  Morgan O'Hayre; Maria S Degese; J Silvio Gutkind
Journal:  Curr Opin Cell Biol       Date:  2014-02-06       Impact factor: 8.382

2.  Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

Authors:  M L Hartman; S M Pincus; M L Johnson; D H Matthews; L M Faunt; M L Vance; M O Thorner; J D Veldhuis
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

3.  G protein mutations in pituitary tumors: a study on Turkish patients.

Authors:  Beki Kan; Christopher Esapa; Tammam Sipahi; Cevdet Nacar; Fahir Ozer; Nur Buyru Sayhan; Mehmet Yaşar Kaynar; Ali Cetin Sarioğlu; Philip Edward Harris
Journal:  Pituitary       Date:  2003-09       Impact factor: 4.107

4.  Prevalence of gsp oncogene in somatotropinomas and clinically non-functioning pituitary adenomas: our experience.

Authors:  Giselle Fernandes Taboada; Ana Lúcia Osório Tabet; Luciana A Naves; Denise Pires de Carvalho; Mônica Roberto Gadelha
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

Review 5.  The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.

Authors:  Morgan O'Hayre; José Vázquez-Prado; Irina Kufareva; Eric W Stawiski; Tracy M Handel; Somasekar Seshagiri; J Silvio Gutkind
Journal:  Nat Rev Cancer       Date:  2013-05-03       Impact factor: 60.716

Review 6.  G Protein-Coupled receptors and heterotrimeric G proteins as cancer drivers.

Authors:  Nadia Arang; J Silvio Gutkind
Journal:  FEBS Lett       Date:  2020-12       Impact factor: 4.124

7.  The curious case of Gαs gain-of-function in neoplasia.

Authors:  Giulio Innamorati; Thomas M Wilkie; Havish S Kantheti; Maria Teresa Valenti; Luca Dalle Carbonare; Luca Giacomello; Marco Parenti; Davide Melisi; Claudio Bassi
Journal:  BMC Cancer       Date:  2018-03-15       Impact factor: 4.430

Review 8.  Update on GNA Alterations in Cancer: Implications for Uveal Melanoma Treatment.

Authors:  Lionel Larribère; Jochen Utikal
Journal:  Cancers (Basel)       Date:  2020-06-10       Impact factor: 6.639

Review 9.  An Insight into GPCR and G-Proteins as Cancer Drivers.

Authors:  Preeti Kumari Chaudhary; Soochong Kim
Journal:  Cells       Date:  2021-11-24       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.